Session (CTI)

This session will explore the evolving landscape of health policies and processes of care across Europe, the United States, and Canada. Speakers will examine initiatives influencing drug approval, pricing, and reimbursement. Additionally, the session will highlight the increasing role of real-world evidence (RWE) in decision-making. Attendees will gain a deeper understanding of the opportunities and challenges in aligning health policies with patient needs within public and private healthcare frameworks.